Wishing our Jewish colleagues around the world a happy and healthy upcoming holiday season! #BelieversintheExtroardinary #BelieversInOurPeople
Karyopharm Therapeutics Inc.
制药业
Newton，MA 32,644 位关注者
Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need.
关于我们
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
- 网站
-
https://www.karyopharm.com
Karyopharm Therapeutics Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Newton，MA
- 类型
- 上市公司
- 创立
- 2008
- 领域
- oncology、pharmaceutical、biotech、multiplemyeloma、lymphoma、solidtumors、glioblastoma、clinicalresearch、clinicaltrials、research、drugdiscovery、medical和healthcare
地点
-
主要
获取路线
85 Wells Avenue
US，MA，Newton，02459
Karyopharm Therapeutics Inc.员工
动态
-
As we continue our mission to advance cancer treatment, the opportunity to make a difference in patients' lives is boundless. Ready to be part of something truly impactful? Join us on this important journey! Explore our career opportunities and help shape the future of cancer care. https://lnkd.in/eWF_24pT #pharmajobs #lifesciences #biopharmacareers #clinicaltrials #remotework?
-
-
Are you attending the 21st annual International Myeloma Society #IMS2024? Our team is here and looking forward to the presentation of four selinexor posters, as part of our focus on continued research to help improve outcomes for patients with Multiple Myeloma. #BelieversInTheExtraordinary #BelieversInPatients
-
-
September 24th marks #WorldCancerResearchDay. Today and everyday, we're committed to pioneering novel cancer therapies for patients. Learn more about our science: https://bit.ly/3Z0gjlo #BelieversintheExtraordinary
-
-
We are happy to be attending the 21st International Myeloma Society Annual Meeting! Join us for our four selinexor poster presentations. Learn more: https://bit.ly/47qRaTc #IMS2024 #BelieversintheExtraordinary #BelieversInScience
-
-
September is Gynecologic Cancer Awareness Month. The Foundation for Women’s Cancer (FWC) estimates that over 116,000 women will be diagnosed with gynecologic cancers in the United States, this year alone.?Please join us in participating in #Move4Her 2024 to support more education and research for #gyncancers.?Take a look at FWC resources and ways to get involved: https://lnkd.in/gSzHDcmX #BelieversInTheExtraordinary #BelieversInPatients?
-
-
September 15th is the 20th anniversary of #WorldLymphomaAwarenessDay. This year's focus is on Honest Talk-- the conversations that can help lymphoma patients and their loved ones address emotional concerns and to help them foster better, more supportive relationships. #WLAD2024 #BelieversintheExtraordinary #BelieversinPatients
-
-
Lisa A. DiPaolo, EVP, Chief Human Resources Officer at Karyopharm Therapeutics Inc. has been named Leader of the Year in New Possible American HR Awards for her transformative contributions to Karyopharm. Lisa’s efforts to foster a collaborative culture across the organization are essential to deliver medicines that move us closer to achieving our mission of positively impacting patients’ lives and defeating cancer.?Please join us in celebrating this well-deserved achievement! #BelieversInTheExtraordinary #BelieversInOurPeople
-